FindMyRecallSubscribe
Class I: serious health riskTerminated

SCA Pharmaceuticals Heparin Sodium 5 Recall

Heparin Sodium 5,000 units in 0

SCA Pharmaceuticals · Windsor, CT

Risk level
Class I
Reported by FDA
Sep 2, 2020
Recall ID
D-1551-2020
Check your lot numberHow we source this data

Summary

SCA Pharmaceuticals recalled Heparin Sodium 5 starting Jul 29, 2020. The FDA classified it as Class I (serious health risk) and published enforcement report D-1551-2020 on Sep 2, 2020. Reason: Cross Contamination with Other Product(s): containers labeled as having methylparaben and propylparaben as preservatives, actually contained undeclared benzyl alcohol and did not contain any parabens. Status: Terminated.

Why it was recalled

Cross Contamination with Other Product(s): containers labeled as having methylparaben and propylparaben as preservatives, actually contained undeclared benzyl alcohol and did not contain any parabens.

Product description

Heparin Sodium 5,000 units in 0.9% Sodium Chloride 500 mL, Single Dose Container, Rx Only Injection for Intravenous Use (10 units/mL), SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT 06095, NDC#: 70004-0650-44, Bar Code 70004065044.

Lot numbers, UPCs & expiration codes

Lot #: 1220019289, Exp 08/21/2020.

Where it was sold

Nationwide within the U.S.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1551-2020
Classification
Class I
Status
Terminated
Recall initiated
Jul 29, 2020
FDA report date
Sep 2, 2020
Quantity
366 Containers
Recall type
Voluntary: Firm initiated
Recalling firm
SCA Pharmaceuticals

Original FDA data

Every field from FDA enforcement report D-1551-2020, exactly as published.

Show all FDA fields
City
Windsor
State
CT
Status
Terminated
Country
United States
Event ID
86193
Address
755 Rainbow Rd Ste B
Code information
Lot #: 1220019289, Exp 08/21/2020.
Postal code
06095-1024
Report date
Sep 2, 2020
Product type
Drugs
Recall number
D-1551-2020
Classification
Class I
Recalling firm
SCA Pharmaceuticals
Product quantity
366 Containers
Termination date
May 21, 2021
Reason for recall
Cross Contamination with Other Product(s): containers labeled as having methylparaben and propylparaben as preservatives, actually contained undeclared benzyl alcohol and did not contain any parabens.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Heparin Sodium 5,000 units in 0.9% Sodium Chloride 500 mL, Single Dose Container, Rx Only Injection for Intravenous Use (10 units/mL), SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT 06095, NDC#: 70004-0650-44, Bar Code 70004065044.
Distribution pattern
Nationwide within the U.S.
Recall initiation date
Jul 29, 2020
Initial firm notification
Letter
Center classification date
Aug 27, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1551-2020, published Sep 2, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls